ZYME Q1 2024 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-71.8% YoY

Gross Profit

$10M100.0% margin

Operating Income

-$38M-376.9% margin

Net Income

-$32M-315.6% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

-40.7%

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$554M

Total Liabilities

$116M

Stockholders' Equity

$438M

Cash & Equivalents

$115M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$36M	-71.8%
Gross Profit	$10M	-$10M	+202.0%
Operating Income	-$38M	-$27M	-38.6%
Net Income	-$32M	-$24M	-30.0%

Revenue Segments

Research Support Payments And Other Service

$2M100%